Oncology Informatics: Status Quo and Outlook.

Artificial intelligence Cancer Electronic health record Electronic patient-reported outcome measures Informatics Machine learning Oncology Radiation oncology

Journal

Oncology
ISSN: 1423-0232
Titre abrégé: Oncology
Pays: Switzerland
ID NLM: 0135054

Informations de publication

Date de publication:
2020
Historique:
received: 27 03 2020
accepted: 27 03 2020
pubmed: 15 5 2020
medline: 27 6 2020
entrez: 15 5 2020
Statut: ppublish

Résumé

Oncology has undergone rapid progress, with emerging developments in areas including cancer stem cells, molecularly targeted therapies, genomic analyses, and individually tailored immunotherapy. These advances have expanded the tools available in the fight against cancer. Some of these have seen broad media coverage resulting in justified public attention. However, these achievements have only been possible due to rapid developments in the expanding field of biomedical informatics and information technology (IT). Artificial intelligence, radiomics, electronic health records, and electronic patient-reported outcome measures (ePROMS) are only a few of the developments enabling further progress in oncology. The promising impact of IT in oncology will only become reality through a multidisciplinary approach to the complex challenges ahead.

Identifiants

pubmed: 32408309
pii: 000507586
doi: 10.1159/000507586
pmc: PMC8882056
mid: NIHMS1781417
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

329-331

Subventions

Organisme : NCI NIH HHS
ID : R01 CA233487
Pays : United States

Informations de copyright

© 2020 S. Karger AG, Basel.

Références

BJR Open. 2019 Jul 04;1(1):20190021
pubmed: 33178948
Oncology. 2020;98(6):423-429
pubmed: 31734663
JMIR Mhealth Uhealth. 2018 Feb 20;6(2):e45
pubmed: 29463489
Br J Radiol. 2020 Feb 1;93(1106):20190855
pubmed: 31965813
Nature. 2017 Jun 28;546(7660):686
pubmed: 28658222
JMIR Mhealth Uhealth. 2018 Aug 30;6(8):e10916
pubmed: 30166275
Oncology. 2020;98(6):396-402
pubmed: 31177262
Sci Rep. 2019 Aug 29;9(1):12495
pubmed: 31467326
JCO Clin Cancer Inform. 2018 Dec;2:1-10
pubmed: 30652571
Cancer Res. 2019 Nov 1;79(21):5463-5470
pubmed: 31395609
Nat Rev Clin Oncol. 2017 Dec;14(12):749-762
pubmed: 28975929
Oncology. 2020;98(6):412-422
pubmed: 31940605
Nat Med. 2019 Jun;25(6):954-961
pubmed: 31110349
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28423407
Oncology. 2020;98(6):363-369
pubmed: 30439700
Oncology. 2020;98(6):403-411
pubmed: 31794967
Oncology. 2020;98(6):430-437
pubmed: 31901906
Nature. 2020 Oct;586(7829):E14-E16
pubmed: 33057217
Oncology. 2020;98(6):344-362
pubmed: 30472716
Oncology. 2020;98(6):370-378
pubmed: 30227426
JAMA. 2017 Jul 11;318(2):197-198
pubmed: 28586821
Oncology. 2020;98(6):438-444
pubmed: 32428914
Oncology. 2020;98(6):379-385
pubmed: 30517946
Oncology. 2020;98(6):386-395
pubmed: 31336377

Auteurs

Paul Martin Putora (PM)

Department of Radiation Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland, PaulMartin.Putora@kssg.ch.
Department of Radiation Oncology, University of Bern, Bern, Switzerland, PaulMartin.Putora@kssg.ch.

Michael Baudis (M)

Department of Molecular Life Sciences and Swiss Institute of Bioinformatics, University of Zurich, Zurich, Switzerland.

Beth M Beadle (BM)

Department of Radiation Oncology, Stanford University, Stanford, California, USA.

Issam El Naqa (I)

Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.

Frank A Giordano (FA)

Department of Radiation Oncology, University of Bonn, Bonn, Germany.

Nils H Nicolay (NH)

Department of Radiation Oncology, University of Freiburg - Medical Center, Freiburg, Germany.
German Cancer Consortium Partner Site Freiburg, German Cancer Research Center, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH